CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
BackgroundColorectal cancer (CRC) remains a predominant contributor to cancer-related mortality globally, with its resistance to immunotherapeutic strategies presenting a formidable challenge in patient management. Recent investigations have illuminated the prospective involvement of ferroptosis, a...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2025-07-01
|
| 叢編: | Frontiers in Immunology |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589423/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|